- Home
- CWAN vs CHE Comparison
CWAN vs CHE Comparison
Compare CWAN & CHE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CWAN | CHE |
|---|---|---|
| Founded | 2004 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Nursing Services |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.8B | 5.6B |
| IPO Year | 2021 | 1994 |
Fundamental Metrics
Financial Performance| Metric | CWAN | CHE |
|---|---|---|
| Price | $24.17 | $383.76 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 11 | 4 |
| Target Price | $25.09 | ★ $498.00 |
| AVG Volume (30 Days) | ★ 4.1M | 213.5K |
| Earning Date | 04-29-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 0.64% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 18.34 |
| Revenue | $731,368,000.00 | ★ $2,529,978,000.00 |
| Revenue This Year | $31.67 | $6.56 |
| Revenue Next Year | $18.27 | $6.23 |
| P/E Ratio | ★ N/A | $20.41 |
| Revenue Growth | ★ 61.88 | 4.06 |
| 52 Week Low | $15.74 | $365.21 |
| 52 Week High | $25.07 | $583.96 |
Technical Indicators
Market Signals| Indicator | CWAN | CHE |
|---|---|---|
| Relative Strength Index (RSI) | 70.16 | 47.50 |
| Support Level | $24.05 | $365.21 |
| Resistance Level | $24.28 | $398.00 |
| Average True Range (ATR) | 0.08 | 8.88 |
| MACD | 0.01 | 1.27 |
| Stochastic Oscillator | 92.50 | 48.07 |
Price Performance
Historical ComparisonAbout CWAN Clearwater Analytics Holdings Inc.
Clearwater Analytics describes its mission as aiming to be the world's most trusted and comprehensive technology platform for the entire investment cycle. Clearwater has historically focused on back-office functions such as investment accounting, but with acquisitions such Enfusion, Beacon, and Bistro, the firm has broadened its focus with front-office and middle-office capabilities. Clearwater primarily serves insurance companies, asset managers, hedge funds, and corporate treasuries. Pro forma for Enfusion, about 76% of Clearwater's revenue is generated in the US.
About CHE Chemed Corp
Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. The company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.